Sempulse® Halo™ Platform Selected for Project Convergence Capstone 5 (PC-C5) with the U.S. Army
Barstow, CA – March 14, 2025 – Sempulse, a leader in next-generation medical technology, is proud to announce its participation in the U.S. Army’s Project Convergence Capstone 5 (PC-C5), a joint multinational modernization experiment taking place in March and April 2025, at military installations across the United States. As the only medical device startup featured in the live-fire exercise that is production-ready, Sempulse continues to demonstrate its commitment to advancing battlefield medical capabilities.
Project Convergence is the U.S. Army’s premier initiative to integrate cutting-edge technologies into multi-domain operations. Launched in 2020, Project Convergence brings together the latest advancements in artificial intelligence, robotics, and medical technology to enhance the lethality, survivability, and effectiveness of military personnel. PC-C5 represents the culmination of years of research and field exercises, with an increased focus on real-world application and readiness.
Sempulse was invited to participate in PC-C5 due to its groundbreaking non-invasive Halo vital signs monitoring system, which provides real-time, mission-critical health data without the need for traditional wired sensors. Designed for rapid deployment in austere environments, the Sempulse device delivers crucial medical insights to first responders and command units, improving triage efficiency, and enhancing battlefield survivability. Sempulse Halo devices will be placed on simulated casualties for medical evacuation (MEDEVAC) and patient movement purposes.
Kurt Stump, Founder and CEO of Sempulse, was onsite for the training and live-fire exercises, working closely with military personnel to demonstrate the device’s capabilities. “Being part of Project Convergence Capstone 5 is a significant milestone for Sempulse,” said Stump. “We are honored to contribute to the Army’s vision for the future of far forward warfighter care and to showcase how our technology can enhance medical response times in combat scenarios.” Stump also presented to representatives from the UK and French militaries about their testing and deployment of the Halo device.
Sempulse’s inclusion in PC-C5 underscores the increasing importance of rugged, portable, and efficient medical technology in modern, near-peer warfare. With the ability to continuously monitor vital signs such as SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, Sempulse is poised to redefine battlefield triage and remote medical monitoring. The company’s collaboration with the U.S. Army highlights a shared commitment to leveraging cutting-edge innovation to save lives and optimize combat medical operations.
As PC-C5 progresses, Sempulse will continue to work closely with military stakeholders to further refine and optimize its technology and its integration with BATDOK®, or Battlefield Assisted Trauma Distributed Observation Kit, which is a mobile medical documentation tool developed by the Air Force Research Laboratory (AFRL) that enables medics to monitor multiple patients’ vital signs, capture treatment history, and integrate patient data while in the field. The insights gained from this exercise will contribute to future enhancements and broader defense applications, ensuring that service members receive the best possible medical support in critical environments.
For more information about Sempulse and its role in the US Army’s Project Convergence Capstone 5, visit sempulse.com.
About Sempulse:
Founded in 2016, Sempulse is a medical device manufacturer with offices in San Marcos, TX. They are a leading innovator in wearable medical technology. They have developed and patented the first true FDA-cleared medical wearable: a novel, non-invasive vital signs sensor that adheres to the neck and the back of the ear and acquires multiple patients’ vital signs while at rest or on the go, including SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, plus geolocation and a wealth of environmental information. Sempulse empowers first responders, clinicians, and industry with real-time physiological data inside or out of the hospital, improving patient outcomes when every second counts.
Sempulse’s Halo Platform recently saved its first life. The Sempulse Halo, including the Halo sensor device, the LiveCharts app, and the Command Cloud application, provided real-time physiological data that led to life-saving action in Gwinnett County, GA.
###
If you would like more information about this topic or to speak with the CEO, please email pr@sempulse.com.